Anavex Life Sciences
AVXL
#7715
Rank
A$0.52 B
Marketcap
A$5.91
Share price
-5.92%
Change (1 day)
-58.33%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -A$73.29 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$73.81 Million a decrease over its 2023 earnings that were of -A$64.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.29 Million-0.7%
2024 -A$73.81 Million14.77%
2023 -A$64.31 Million-17.49%
2022 -A$77.94 Million22.96%
2021 -A$63.39 Million35.36%
2020 -A$46.83 Million12.65%
2019 -A$41.57 Million29.09%
2018 -A$32.2 Million36.33%
2017 -A$23.62 Million17.11%
2016 -A$20.17 Million20.91%
2015 -A$16.69 Million-6.29%
2014 -A$17.81 Million337.28%
2013 -A$4.08 Million
2008 -A$7.53 Million106.01%
2007 -A$3.66 Million8848.98%
2006 -A$0.05 Million-79.99%
2005 -A$0.21 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
A$95.62 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
A$93.87 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$6.87 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-A$9.48 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA